Promatix Biosciences presented new data at AAC) Annual Meeting 2026, addressing a key bottleneck in the development of ADC.
Revenue in the first quarter of 2026 amounted to EUR 1,547.0 million, an 0.8% decrease compared to the first quarter of 2025. The Group delivered an organic growth of 4.5%. By business, and on an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results